Mannatech Announces Notification of Late Filing
Rhea-AI Summary
Mannatech (NASDAQ: MTEX) filed a Form 12b-25 notifying the SEC of a late annual report filing for its 2025 Form 10-K.
The Form 12b-25 grants an automatic 15-calendar-day extension beyond the March 31, 2026 due date, and the company expects to file the 2025 Form 10-K by April 15, 2026. The 12b-25 filing is available on the company investor site.
Positive
- Filed Form 12b-25 to secure a 15-day automatic extension
- Company set a clear expected filing date of April 15, 2026
Negative
- 2025 Form 10-K was not filed by the original due date March 31, 2026
- Public delay may temporarily limit investor access to audited annual disclosures
News Market Reaction – MTEX
On the day this news was published, MTEX declined 8.39%, reflecting a notable negative market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
MTEX shows a +9.35% move while peers are mixed: HFFG +9.68%, WILC +6.08%, TWG +2.72%, CVGW +1.95%, and DIT -0.90%. With only one peer in the momentum scanner and mixed directions, trading appears stock-specific rather than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Nov 12 | Q3 2025 earnings | Neutral | +0.1% | Reported lower sales but stronger margins and swing to quarterly net income. |
The lone recent earnings-related release showed minimal price impact, suggesting historically muted reactions to fundamental updates.
In recent months, Mannatech’s key disclosures centered on financial performance and filings. On Nov 12, 2025, Q3 2025 results showed net sales of $29.2M (down 8.1% year over year) but improved profitability, with income from operations of $2.0M and net income of $1.9M or $1.01 per diluted share. The stock moved only 0.11% after that report. Today’s late 10-K notification follows that backdrop of softer sales but better margins and limited historical price reactions to news.
Market Pulse Summary
The stock moved -8.4% in the session following this news. A negative reaction to a late 10-K filing would have fit a risk-focused interpretation of the news. Historically, however, Mannatech’s disclosures, like the Q3 2025 earnings release that saw only a 0.11% move, have not triggered large swings. Any sharp downside move could reflect heightened concern about reporting timing rather than a confirmed change in underlying performance, which previously showed weaker sales but better margins.
Key Terms
form 12b-25 regulatory
form 10-k regulatory
rule 12b-25 regulatory
AI-generated analysis. Not financial advice.
FLOWER MOUND, Texas, April 01, 2026 (GLOBE NEWSWIRE) -- Mannatech, Incorporated (NASDAQ: MTEX), (“Mannatech” or “the Company”) announced today that it has filed a Form 12b-25, Notification of Late Filing, with the U.S. Securities and Exchange Commission with regard to its annual report on Form 10-K (the “2025 Form 10-K”) for the fiscal year ended December 31, 2025. Form 12b-25 allows the Company an automatic extension of 15 additional calendar days to file the 2025 Form 10-K, which is due on March 31, 2026.
The Company expects to file the 2025 Form 10-K as soon as practicable by April 15, 2026, in accordance with Rule 12b-25. The 12b-25 filing is available on the Company’s website under ir.Mannatech.com.
About Mannatech:
Mannatech is a leading global health and wellness company committed to empowering everyone to live their best life through cutting-edge, science-backed nutritional products, patented technology, and a rewarding business opportunity. With operations in more than 25 markets†, Mannatech helps people to live healthier, more fulfilling lives while making a positive social impact in the world. Individuals interested in Mannatech's products or in exploring its business opportunity can learn more at Mannatech.com.
†Mannatech operates in China under a cross-border e-commerce platform that is separate from its network marketing model.
Please Note: This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. These forward-looking statements generally can be identified by use of phrases or terminology such as “may,” “will,” “should,” "hope," “could,” “would,” “expects,” “plans,” “intends,” “anticipates,” “believes,” “estimates,” “approximates,” “predicts,” “projects,” “potential,” and “continues” or other similar words or the negative of such terminology. Similarly, descriptions of Mannatech’s objectives, strategies, plans, goals, or targets contained herein are also considered forward-looking statements. Mannatech believes this release should be read in conjunction with all of its filings with the United States Securities and Exchange Commission and cautions its readers that these forward-looking statements are subject to certain events, risks, uncertainties, and other factors. Some of these factors include, among others, the impact of COVID-19 on Mannatech's business, Mannatech’s inability to attract and retain associates and members, increases in competition, litigation, regulatory changes, and its planned growth into new international markets. Although Mannatech believes that the expectations, statements, and assumptions reflected in these forward-looking statements are reasonable, it cautions readers to always consider all of the risk factors and any other cautionary statements carefully in evaluating each forward-looking statement in this release, as well as those set forth in its latest Annual Report on Form 10-K, and other filings filed with the United States Securities and Exchange Commission, including its current reports on Form 8-K. All of the forward-looking statements contained herein speak only as of the date of this release.
Contact Information:
Erin K. Barta
General Counsel and Corporate Secretary
972.471.6512 or ir@mannatech.com
www.mannatech.com
